Anti-C5 antibody treatment for delayed hemolytic transfusion reactions in sickle cell disease.

MLA

Floch, Aline, et al. “Anti-C5 Antibody Treatment for Delayed Hemolytic Transfusion Reactions in Sickle Cell Disease.” Haematologica, vol. 105, no. 11, Nov. 2020, pp. 2694–97. EBSCOhost, https://doi.org/10.3324/haematol.2020.253856.

APA

Floch, A., Morel, A., Zanchetta-Balint, F., Cordonnier-Jourdin, C., Allali, S., Grall, M., Ithier, G., Carpentier, B., Pakdaman, S., Merle, J.-C., Goulabchand, R., Khalifeh, T., Berceanu, A., Helmer, C., Chantalat-Auger, C., Frémeaux-Bacchi, V., Michel, M., de Montalembert, M., Mekontso-Dessap, A., … Bartolucci, P. (2020). Anti-C5 antibody treatment for delayed hemolytic transfusion reactions in sickle cell disease. Haematologica, 105(11), 2694–2697. https://doi.org/10.3324/haematol.2020.253856

Chicago

Floch, Aline, Alexandre Morel, Fabian Zanchetta-Balint, Catherine Cordonnier-Jourdin, Slimane Allali, Maximilien Grall, Ghislaine Ithier, et al. 2020. “Anti-C5 Antibody Treatment for Delayed Hemolytic Transfusion Reactions in Sickle Cell Disease.” Haematologica 105 (11): 2694–97. doi:10.3324/haematol.2020.253856.